New study aims to boost HIV prevention in meth-using men
NCT ID NCT06637436
First seen Feb 06, 2026 · Last updated May 21, 2026 · Updated 19 times
Summary
This study tests two approaches to help men who have sex with men and use methamphetamine get HIV prevention (PrEP) or treatment (ART) medication. About 400 men will be randomly assigned to receive either contingency management (rewards for filling prescriptions) alone or combined with motivational interviewing. The goal is to see which method works better at getting them to fill their medication and reduce risky behaviors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Florida International University
RECRUITINGMiami, Florida, 33199, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.